Epidemiology of Acute Self-poisoning in Emergency Services in France
NCT ID: NCT02518386
Last Updated: 2019-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
700 participants
OBSERVATIONAL
2015-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Investigators will conduct a 48h observational study in emergency services in France. Investigators primary objective is to gathered epidemiological clinical and treatment data during emergency dispatch, prehospital care and inhospital emergency care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
NCT03481192
Divided Drug Delivery
NCT02869724
New Psychoactive Substances in Intoxicated Patients During the Winter Activities
NCT04155281
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
NCT05696691
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Epidemiological, clinical, toxicological and treatment data will be gathered. Outcome of patient will be prospectively assessed at 30days.
All data will be transmitted to the principal investigators. Then, 20% of the data will be monitored by an independent committee.
Exhaustivity will be retrospectively assessed by the number of inclusions in 10 emergency centers divided by the total number of possible inclusions in these centers.
Finally, an independent statistician will be in charge of the analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention is planned
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* acute self poisoning without any medication intake
* non intentional poisoning
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
French Society of Emergency Medicine
OTHER
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxime Maignan, MD MSc
Role: PRINCIPAL_INVESTIGATOR
Emergency department, CHU Grenoble
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EpiTox
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.